Bivictrix Therapeutics optimistic about BVX002 after in vivo testing
9th Sep 2024 15:35
(Alliance News) - Bivictrix Therapeutics PLC announced on Monday it has received "positive" in vivo test results from its BVX002 solid tumour programme. Read More